ArticleFrontiers in reproductive health2026
Corifollitropin alfa versus daily recombinant FSH for ovarian stimulation in women of advanced maternal age: a cost-minimization analysis in an out-of-pocket setting.
G N Cecchino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.